NADC34-like porcine reproductive and respiratory syndrome virus (PRRSV) has been circulating in China for several years, causing substantial economic losses to the local pig industry. Current commercial vaccines have failed to provide complete protection against NADC34-like PRRSV infection. Additionally, the poor adaptation of NADC34-like strains to Marc-145 cells presents a considerable challenge for developing effective vaccines against these strains. This study addresses these challenges by developing a novel vaccine candidate against NADC34-like PRRSV. We engineered a recombinant PRRSV, rNADC34-CHSps, by replacing the structural protein region of the JS2021NADC34 strain with that of the CHR6 strain to improve its adaptation to Marc-145 cells. The rescued strain could proliferate well in Marc-145 cells, maintaining high titers and stable growth kinetics even at high passage numbers. Piglets were vaccinated with rNADC34-CHSps at passage 80 and then challenged with the virulent NADC34-like PRRSV strain, JS2021NADC34, at 28 days post-vaccination. All vaccinated piglets developed specific antibodies against PRRSV at 14 dpv and showed no significant clinical symptoms, even after exposure to PRRSV JS2021NADC34. Furthermore, the vaccinated piglets gained significantly more weight, displayed much less severe pathological lesions, and reduced viremia compared to the challenge control piglets. These results indicate that rNADC34-CHSps is a promising vaccine candidate against NADC34-like PRRSV infection, highlighting the potential of targeted genomic modifications to enhance vaccine efficacy.
PRRSV poses a persistent global challenge to the swine industry due to its rapid evolution. This study aimed to characterize a novel PRRSV2 strain, HeB2023092, isolated from a suspected outbreak in China in September 2023. We performed virus isolation in porcine alveolar macrophages (PAMs), genome sequencing, phylogenetic analysis, and comprehensive genetic characterization. HeB2023092 replicated effectively in PAMs but not in Marc-145 cells. Phylogenetic analysis consistently grouped it with NADC30-like strains (L1.8). Notably, genomic analysis revealed a unique 41-amino acid deletion (478–518 aa) in Nsp2, in addition to the characteristic 111-amino acid deletion of NADC30-like strains. Significant amino acid variations were also found in the antigenic epitopes and N-glycosylation patterns of GP3 and GP5. Comprehensive recombination analysis identified three distinct recombinant regions, revealing a mosaic genome with a predominant NADC30-like backbone. The backbone incorporated genetic sequences from JXA1-like (L8.7) strains in two regions and from NADC34-like (L1.5) strains in one region. These findings highlight the continuous genetic evolution and complex epidemiology of PRRSV, underscoring the critical need for sustained surveillance and detailed characterization of circulating strains to inform effective control and vaccine development strategies.
Pseudorabies virus (PRV) remains a critical threat for the global swine industry, with heightened attention due to the emergence of variant strains since late 2011 in China. Emergent viral variants generally undergo three to four years of adaptation to present new phenotypes. However, limited investigations have been performed on the evolution and pathogenicity of variant PRV strains in growing pigs after 2015. In this study, three PRV field strains, named SD1501, SD1701, and SD1801, were isolated and their genetic characteristics and pathogenicity on 9-week-old pigs were analyzed. Nucleotide identity and phylogenetic analyses based on the complete genome sequence, as well as major immunogenic and virulence-related genes revealed that all three isolates clustered closely with genotype II variant strains prevalent in China. The pathogenicity analysis demonstrated that the three isolates exhibited moderate pathogenicity in growing pigs with a TCID50 of 107. Infected pigs displayed transient fever and reduced appetite, with only one pig in each challenge group showing typical neurological symptoms and succumbing within 6 days post infection. These findings enrich the epidemiological data of PRV and provide direct evidence for the phenotypic variations caused by PRV infection, which enhances our understanding of PRV evolution in China and contributes to PRV control in the field.